Researchers across UCL are applying artificial intelligence in powerful ways to accelerate Alzheimer's diagnosis, track disease progression and develop new treatments.
Dementia is one of the greatest health challenges of our time, with the number of people living with dementia in the UK now estimated to be close to one million and projected to rise to 1.4 million by 2040. Over 60% of people living with the condition are thought to have Alzheimer's disease.
UCL is determined to tackle this growing crisis with one of the world's largest neuroscience communities, strong partnerships with industry, funders, and patients, and the construction of a new state-of-the-art facility on Grays Inn Road, which will accelerate treatment discovery and train future scientists.
Since it was founded nearly 200 years ago, UCL has made countless groundbreaking neuroscience advances, including the first identification of a brain protein's central role in Alzheimer's disease, research which has led to promising new drugs hailed as a turning point in tackling the disease. This World Alzheimer's Day (21 September), we showcase some of the ways that UCL researchers are now applying cutting-edge AI to transform the way we understand, diagnose and treat Alzheimer's disease.
Third-party hosted content
This content is hosted on YouTube. Third-party embedded content may include its own cookies for analytics, marketing, and functionality. Please accept embedded content cookies to view this content or access it directly.
https://www.youtube.com/embed/QKQvycYcP30?feature=oembedAccept embedded content cookies
Using AI to accelerate discovery
Many of us are embracing AI 'digital helpers' or agents to speed up our daily tasks, but how might AI agents fast-track breakthroughs in dementia? Dr Mathieu Bourdenx, Senior Research Fellow at the UK Dementia Research Institute (UKDRI) at UCL, is working with the non-profit organisation FutureHouse to use an 'AI scientist'.
